Kenya Takes Major Step Towards Digital Health Transformation with New Regulations
Digital health innovations are poised to transform the healthcare landscape in Kenya, and today, Cabinet Secretary Hon Aden Duale EGH, led an important discussion with the National Assembly Committee on Delegated Legislation, chaired by Ainabkoi MP Hon. Samuel Chepkonga, on the Digital Health Regulations 2025. The meeting, held at a Kiambu Hotel, focused on the regulations currently at the prepublication stage.
The proposed regulations aim to establish a robust framework for digital health services, facilitating the registration of patients, tracking of health records, and streamlining healthcare processes. By implementing these regulations, Kenya is poised to accelerate its progress in addressing health priorities in alignment with major national development frameworks, such as Vision 2030 and the Bottom-Up Economic Transformation Agenda (BETA), where healthcare is a critical focus.
Hon. Duale highlighted that these regulations are part of the government's broader efforts to improve healthcare access, making services more affordable, high-quality, and financially sustainable for all Kenyans. He also expressed confidence that the regulations would combat healthcare fraud and address the growing issue of unqualified medical practitioners.
The meeting also saw the participation of key officials, including Medical Services PS Mr. Harry Kimtai, Acting CEO of the Digital Health Agency (DHA) Mr. Anthony Lenaiyara, Senior Counsel Ms. Edith Torome, and other Ministry representatives.
Distributed by APO Group on behalf of Ministry of Health, Kenya.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
2 days ago
- Zawya
Saudi Arabia's health sector sees 145% surge in beneficiaries in 2024
RIYADH — Saudi Arabia's Health Sector Transformation Report for 2024 has revealed substantial improvements in the quality, accessibility, and efficiency of healthcare services, aligned with the Kingdom's Vision 2030 objectives. According to the report, more than 33 million individuals benefited from the services and pathways of the Saudi healthcare model by the end of 2024 — a 145% increase compared to the previous year. The integrated model is designed to deliver tailored, comprehensive healthcare that meets the varying health and age-related needs of the population. Patient satisfaction with medical services reached 83.38%, reflecting enhanced service integration and overall improvement in healthcare delivery across the Kingdom's regions. Insurance coverage also saw significant growth, with over 13 million beneficiaries now accessing health services through insurance schemes, supporting greater equity and access across different segments of society. On the workforce front, the report highlighted that more than 30,000 individuals have graduated from Saudi Board programs since their inception. The number of Board seats increased by 71% compared to 2021, underscoring the Kingdom's commitment to empowering national healthcare professionals and sustaining the sector. Saudi Arabia also led the region in promoting healthy living environments. In 2024, 16 cities were designated as 'healthy cities' in line with World Health Organization standards — the highest number in the region. These designations aim to improve quality of life and support healthier lifestyles across urban centers. © Copyright 2022 The Saudi Gazette. All Rights Reserved. Provided by SyndiGate Media Inc. (
Gulf Business
2 days ago
- Gulf Business
Innovation, expansion, IPO: SMC Healthcare's Bassam Chahine charts its ambitious growth
Image: Supplied As Saudi Arabia intensifies efforts to diversify its economy under Vision 2030, the healthcare sector emerges as a pivotal focus. The company recently initiated plans for an initial public offering (IPO) on the Saudi stock exchange, collaborating with banks such as EFG Hermes and SNB Capital to facilitate the process. This strategic move aims to bolster SMC's expansion, including the development of three new hospitals in northern Riyadh, thereby more than doubling its current bed capacity. In this interview with Gulf Business , CEO Bassam Chahine discusses the company's growth strategy, digital innovations, and its alignment with the kingdom's evolving healthcare landscape. SMC's IPO marks a major milestone in your 25-year journey. What strategic goals are you looking to achieve through this listing, and how does it support your expansion into Northern Riyadh? The IPO is a natural evolution of our 25-year legacy in Riyadh and marks a pivotal chapter in our growth journey. Since launching as a single-day surgery centre, we have transformed into one of the leading multi-specialty healthcare providers in the kingdom. This listing will allow us to accelerate our expansion plans, particularly in Northern Riyadh — one of the capital's fastest-growing corridors. Our three new hospitals are strategically locate in rapidly developing neighbourhoods tied to giga-projects such as New Murabba, NHC suburbs and North Pole. Once operational, they will more than double our capacity to over 1,275 beds, significantly strengthening our footprint in Riyadh's fastest-growing healthcare corridor. The IPO will help us execute this roadmap efficiently, ensuring we are well positioned to meet future demand and remain at the forefront of healthcare delivery in the capital. Read: With three new hospitals under development and the capacity set to more than double, how is SMC preparing to meet the operational demands and talent needs of this significant scale-up? We are scaling with discipline. We have centralised key operational functions such as revenue cycle management, procurement, HR, and IT, which reduces overhead duplication as we grow. From an infrastructure perspective, we've invested early in systems and workflows that allow us to integrate new facilities seamlessly. On the talent front, SMC Healthcare has a long-standing reputation for attracting world-class clinicians and specialists. Our fixed salary model incentivises long-term commitment, and we complement this with robust professional development programmes. We are also investing in automation and AI tools to streamline clinical and administrative processes, which allows our staff to focus on patient care. The company has posted impressive financial performance, with profit margins more than doubling in three years. What are the key levers driving this growth, and how do you plan to sustain it post-IPO? Our margin expansion—from 5.3 per cent in 2021 to 12.9 per cent in 2024 — has been driven by three deliberate strategic levers. First, we've shifted away from long-term care to higher-margin acute specialties like cardiology, orthopedics, and pediatrics. Second, we've doubled down on outpatient services, which are more scalable and structurally profitable. Third, our digital infrastructure — including our proprietary mobile app and AI-integrated systems, has improved operational efficiency across the board. Post-IPO, we will continue this strategy by optimising our specialty mix, driving higher patient volumes through new outpatient clinics, and maintaining a lean, tech-enabled operating model. As our new hospitals are coming online, we expect to unlock further operating leverage. SMC has embraced AI, digital tools, and telemedicine early. How central is digital transformation to your patient care model and competitive edge in a rapidly evolving healthcare landscape? Digital transformation is integral to our care model and a key differentiator for SMC. Our in-house developed mobile app has over 83,000 users and accounts for 62 per cent of bookings. It handles everything from registration, payments, online check in up to prescription access. This has halved patient waiting times and improved patient throughput. We are also among the first in the kingdom to integrate AI into diagnostics and lab result interpretation. This enhances diagnostic accuracy, speeds up clinical workflows, and supports personalised care delivery. Our tech-first approach not only boosts operational efficiency but ensures that we continue to lead in patient experience, which is increasingly central to competitive healthcare. With the kingdom's Vision 2030 pushing public-private healthcare partnerships, how do you see SMC's role evolving in this new ecosystem — and what opportunities do you see beyond Riyadh? Vision 2030 is unlocking significant opportunities for private healthcare providers. We're already a frontrunner — SMC Healthcare was selected as the preferred bidder to operate the kingdom's first mental health facility under a PPP model in partnership with Dr Ebel Kliniken, and HealthGate. This underscores our capability and credibility as a strategic partner to the government. Our immediate focus remains Riyadh, where demand continues to surge. Northern Riyadh alone will need thousands of new hospital beds by 2035. We're addressing this head-on by becoming the largest private operator in that region. That said, the PPP framework opens new doors across the kingdom — and when the time is right, we will evaluate opportunities in other high-growth cities with the same disciplined, data-driven approach that has defined our growth so far.
Zawya
27-05-2025
- Zawya
Aspen boosts regional expansion via HQ in Riyadh
Riyadh – Aspen Pharmacare Holdings Limited, a global speciality and branded multinational pharmaceutical company, launches a new regional headquarters (HQ) in Riyadh, according to a press release. The Saudi expansion followed a series of Middle East investments in key therapeutic areas to meet the market demands and support Aspen's growth strategy, which focuses on talent development, localization, and partnerships. Daniel Vella Friggieri, Regional CEO Europe and Middle East, Aspen Pharmacare, said: 'The large-scale changes that have occurred in Saudi Arabia's healthcare landscape offer us a tremendous opportunity. Aspen's new regional headquarters in Riyadh ensures that we can fully align with the Kingdom's healthcare delivery objectives and mutual goal setting under Vision 2030.' Wesam Nehad, Aspen Pharma RHQ General Manager, commented: 'Expanding in Saudi Arabia allows Aspen to build on our already well-established, strong capabilities across the Middle East – namely, an efficient distribution network, operational excellence, and a highly skilled team.' It is worth indicating that Aspen focuses on marketing and manufacturing a wide range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets through its key business segments. It wide variety of product types includes steriles, oral solid dose, liquids, semi-solids, biologicals, and active pharmaceutical ingredients.
